Assignee
ZEVRA THERAPEUTICS INC
US·6 granted patents·10 pending applications·1 citations·filing 2018–2025
Top patents by PatentIndex Score
16 records- 0188US11753378B2Ketamine compounds and processes for making and using themZEVRA THERAPEUTICS INC·Filed 2022·Granted Sep 12, 2023·1 cites·33 claims
- 0283US2024199551A1D-amphetamine compounds, compositions, and processes for making and using the sameZEVRA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0381US12251445B2Gamma-hydroxybutyrate delivering compounds and processes for making and using themZEVRA THERAPEUTICS INC·Filed 2023·Granted Mar 18, 2025·0 cites·19 claims
- 0480US2025032479A1Levorphanol prodrugs and processes for making and using themZEVRA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0579US2024317688A1Dextrorphan prodrugs and processes for making and using themZEVRA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0677US12091386B2D-amphetamine compounds, compositions, and processes for making and using the sameZEVRA THERAPEUTICS INC·Filed 2021·Granted Sep 17, 2024·0 cites·19 claims
- 0774US12012384B2Dextrorphan prodrugs and processes for making and using themZEVRA THERAPEUTICS INC·Filed 2021·Granted Jun 18, 2024·0 cites·4 claims
- 0874US2025367299A1Gamma-hydroxybutyrate delivering compounds and processes for making and using themZEVRA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0972US12076316B2Levorphanol prodrugs and processes for making and using themZEVRA THERAPEUTICS INC·Filed 2021·Granted Sep 3, 2024·0 cites·15 claims
- 1069US2025186591A1Gamma-hydroxybutyrate delivering compounds and processes for making and using themZEVRA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1164US2023355550A1Ketamine compounds and processes for making and using themZEVRA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1256US2026000661A1Use of arimoclomol in activating clear gene expression as treatment for lysosomal storage disordersZEVRA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1354US2026000662A1Use of arimoclomol in activating clear gene expression as treatment for lysosomal storage disordersZEVRA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1453US12590065B2Levorphanol prodrugs and processes for making and using themZEVRA THERAPEUTICS INC·Filed 2018·Granted Mar 31, 2026·0 cites·6 claims
- 1552US2026098013A1Stereoisomer Conjugates of DextrorphanZEVRA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1650US2025375436A1Serdexmethylphenidate for treatment of idiopathic hypersomniaZEVRA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ZEVRA THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →